<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-25T20:22:29+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>和记黄埔「索凡替尼胶囊」即将获批上市</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/DQVx0XnpJTLHv6w9MPHWrw</id>
    <link href="https://mp.weixin.qq.com/s/DQVx0XnpJTLHv6w9MPHWrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重塑SCLC格局、改写NCCN指南！IMpower133试验设计背后的奥秘</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/b7ZkZBZ7FqKQUEhqBzkYbw</id>
    <link href="https://mp.weixin.qq.com/s/b7ZkZBZ7FqKQUEhqBzkYbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>13个品种通过一致性评价，注射用头孢呋辛钠首家过评</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/BD5VxFljt1l3f03pdlLLdA</id>
    <link href="https://mp.weixin.qq.com/s/BD5VxFljt1l3f03pdlLLdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧狄沃患者援助项目再度更新，年自付比例累计降幅超75%</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/aX8cczPKh3Vt4wlbJyCPOA</id>
    <link href="https://mp.weixin.qq.com/s/aX8cczPKh3Vt4wlbJyCPOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国家集采品规资质线上申报工作今日开启</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/QNBh9sIK69Y1DYLHGU3u8w</id>
    <link href="https://mp.weixin.qq.com/s/QNBh9sIK69Y1DYLHGU3u8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药CDK4/6抑制剂SHR6390 片 III 期临床成功</title>
    <updated>2020-12-25T15:35:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/21Ss2aCDWGQ5lLnEh7FIEA</id>
    <link href="https://mp.weixin.qq.com/s/21Ss2aCDWGQ5lLnEh7FIEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个药物获批2周年到市值突破1000亿 ，信达是如何做到的？</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/VXU0AWNdFqYQi63dLCiqbw</id>
    <link href="https://mp.weixin.qq.com/s/VXU0AWNdFqYQi63dLCiqbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>京津冀药品带量采购联盟来袭，4大形式分类进行</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/eUO3HPS7roiGPWjJOKfP6A</id>
    <link href="https://mp.weixin.qq.com/s/eUO3HPS7roiGPWjJOKfP6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE拟突破性疗法认定：拜耳PI3K抑制剂、冠科美博E-选择素拮抗剂</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/7qh7z17MR-qLXR8Ko0_0Iw</id>
    <link href="https://mp.weixin.qq.com/s/7qh7z17MR-qLXR8Ko0_0Iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药提交「氟唑帕利」新适应症上市申请：卵巢癌维持治疗</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/ko3Pzl1iD1dUK7w05dYMbA</id>
    <link href="https://mp.weixin.qq.com/s/ko3Pzl1iD1dUK7w05dYMbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个每日1次口服前列腺癌新药获FDA批准上市</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/U1GwYiUvKJQx_-9fo5RFkQ</id>
    <link href="https://mp.weixin.qq.com/s/U1GwYiUvKJQx_-9fo5RFkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>悦康药业今日科创板上市，市值140亿，超额募资6亿，1类新药爱地那非报产中</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/9UmG0S24MmJuHKvOTAmFIg</id>
    <link href="https://mp.weixin.qq.com/s/9UmG0S24MmJuHKvOTAmFIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>绿叶制药1类新药完成I期临床研究</title>
    <updated>2020-12-24T15:07:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/2sUtcw5cc0iLaS1ByszN2A</id>
    <link href="https://mp.weixin.qq.com/s/2sUtcw5cc0iLaS1ByszN2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第2款CKD4/6抑制剂！礼来阿贝西利片即将获批上市</title>
    <updated>2020-12-23T15:11:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/npw3ZsNKcfhjAhL6N14maQ</id>
    <link href="https://mp.weixin.qq.com/s/npw3ZsNKcfhjAhL6N14maQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达生物阿达木单抗注射液获批2项新适应症</title>
    <updated>2020-12-23T15:11:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/TIekT9r8AA5kJ6V2fiGkdg</id>
    <link href="https://mp.weixin.qq.com/s/TIekT9r8AA5kJ6V2fiGkdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>7款仿制药通过一致性评价，2款注射剂品种</title>
    <updated>2020-12-23T15:11:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/NWDb1l5mob_8QR9d31-6DQ</id>
    <link href="https://mp.weixin.qq.com/s/NWDb1l5mob_8QR9d31-6DQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11省联盟带量采购即将开启，13个品种采用“双信封”综合评分遴选</title>
    <updated>2020-12-23T15:11:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/dzxc1ADKG3vEEa3JrDvWuw</id>
    <link href="https://mp.weixin.qq.com/s/dzxc1ADKG3vEEa3JrDvWuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业四代EGFR抑制剂申报临床</title>
    <updated>2020-12-23T15:11:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/RDQiTvZ2ZMntZ01ZQvH5YQ</id>
    <link href="https://mp.weixin.qq.com/s/RDQiTvZ2ZMntZ01ZQvH5YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>完全缓解率达72%！IL-15激动剂联合卡介苗治疗膀胱癌III期研究成功</title>
    <updated>2020-12-22T18:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/C1UbPZKDQ-wg6rySkQEG-g</id>
    <link href="https://mp.weixin.qq.com/s/C1UbPZKDQ-wg6rySkQEG-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甲状腺癌死亡风险降低78%！Exelixis 卡博替尼III期临床研究提前揭盲</title>
    <updated>2020-12-22T18:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/OKJcpvBLjOWJXKx0H_AZRg</id>
    <link href="https://mp.weixin.qq.com/s/OKJcpvBLjOWJXKx0H_AZRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>